CXR EDGE
LIVE

Serial Number

79315299

Owner

ANNALISE-AI PTY LTD

Attorney

Martin R. Geissler

Filing Date

Jun 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CXR EDGE Trademark

Serial Number: 79315299 • Registration: 6823137

CXR EDGE is a trademark filed by ANNALISE-AI PTY LTD on June 3, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ANNALISE-AI PTY LTD (5 trademarks)

Level 5, 24 York Street

Entity Type: 99

Trademark Details

Filing Date

June 3, 2021

Registration Date

August 23, 2022

Published for Opposition

June 7, 2022

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 2, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 2, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 1, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 30, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2022 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 31, 2021 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Dec 21, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 20, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 8, 2021 REPR